Gilead Analysts Boost Their Forecasts After Upbeat Q4 Earnings

Gilead Sciences Inc. (NASDAQ:GILD) posted upbeat fourth-quarter earnings but issued weak fiscal 2026 guidance on Tuesday.Gilead reported quarterly earnings of $1.86 per share, which beat the consensus estimate of $1.81, according to data from Benzinga Pro. Quarterly revenue came in at $7.93 billion, which beat the Street estimate of $7.69 billion."Our fourth quarter and full-year results close out a very strong year for Gilead overall, including the successful U.S. launch of Yeztugo, the world's first twice ...